These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28522043)

  • 1. Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients.
    Weber P; Seyed Jafari SM; Yawalkar N; Hunger RE
    J Am Acad Dermatol; 2017 Jun; 76(6):1189-1191. PubMed ID: 28522043
    [No Abstract]   [Full Text] [Related]  

  • 2. Apremilast for the Treatment of Mild-to-Moderate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study.
    Kerdel FR; Azevedo FA; Kerdel Don C; Don FA; Fabbrocini G; Kerdel FA
    J Drugs Dermatol; 2019 Feb; 18(2):170-176. PubMed ID: 30811140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial.
    Vossen ARJV; van Doorn MBA; van der Zee HH; Prens EP
    J Am Acad Dermatol; 2019 Jan; 80(1):80-88. PubMed ID: 30482392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders.
    Aarts P; Vossen ARJV; van der Zee HH; Prens EP; van Straalen KR
    J Am Acad Dermatol; 2021 Jul; 85(1):258-260. PubMed ID: 32891782
    [No Abstract]   [Full Text] [Related]  

  • 5. One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast.
    Lanna C; Mazzilli S; Zangrilli A; Bianchi L; Campione E
    Dermatol Ther; 2019 Nov; 32(6):e13089. PubMed ID: 31577864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.
    Vossen ARJV; van der Zee HH; Davelaar N; Mus AMC; van Doorn MBA; Prens EP
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):761-765. PubMed ID: 30451329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature.
    Garcovich S; Giovanardi G; Malvaso D; De Simone C; Peris K
    Medicine (Baltimore); 2020 Jan; 99(5):e18991. PubMed ID: 32000436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option.
    Hotz C; Sbidian E; Ingen-Housz-Oro S; Chosidow O; Wolkenstein P
    Acta Derm Venereol; 2019 Nov; 99(12):1170-1171. PubMed ID: 31314122
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of efficacy of apremilast in 9 patients with severe alopecia areata.
    Liu LY; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):773-774. PubMed ID: 28917463
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.
    Leslie KS; Tripathi SV; Nguyen TV; Pauli M; Rosenblum MD
    J Am Acad Dermatol; 2014 Feb; 70(2):243-51. PubMed ID: 24314876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
    van der Zee HH; Boer J; Prens EP; Jemec GB
    Dermatology; 2009; 219(2):143-7. PubMed ID: 19590174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of hidradenitis suppurativa successfully treated with apremilast in a patient with psoriasis and SAMPUS.
    Proietti I; Michelini S; Mambrin A; Di Fraia M; Tolino E; Balduzzi V; Bernardini N; Marchesiello A; Porta N; Skroza N; Romeo G; Di Cristofano C; Petrozza V; Potenza C
    Dermatol Ther; 2020 May; 33(3):e13448. PubMed ID: 32323441
    [No Abstract]   [Full Text] [Related]  

  • 17. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
    Morita A; Takahashi H; Ozawa K; Imafuku S; Nakama T; Takahashi K; Matsuyama T; Okubo Y; Kitamura S; Matsuda N; Zhao Y; Yokoyama M; Hayashi N; Terui T
    J Dermatol; 2019 Sep; 46(9):745-751. PubMed ID: 31282051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate to severe hidradenitis suppurativa treated with biological therapies.
    Chinniah N; Cains GD
    Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
    Vekic DA; Frew JW
    Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.